Windlas Biotech Limited (WINDLAS) — Cash Flow Reinvestment Rate
Windlas Biotech Limited (WINDLAS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs67.78 Million. See Windlas Biotech Limited (WINDLAS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Windlas Biotech Limited Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Windlas Biotech Limited across 8 annual periods. For the full cash flow conversion analysis, see Windlas Biotech Limited operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Windlas Biotech Limited (2018–2025)
Year-by-year capital reinvestment analysis for Windlas Biotech Limited. See WINDLAS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.85x | Rs1.26 Billion | Rs681.87 Million | Rs521.94 Million | ▲ +55.5% |
| 2024 | 1.19x | Rs1.30 Billion | Rs1.09 Billion | Rs376.84 Million | ▼ -14.6% |
| 2023 | 1.39x | Rs850.00 Million | Rs609.65 Million | Rs708.90 Million | ▼ -91.9% |
| 2022 | 17.22x | Rs1.57 Billion | Rs91.30 Million | Rs148.04 Million | ▲ +111.4% |
| 2021 | 8.15x | Rs933.19 Million | Rs114.54 Million | Rs58.47 Million | ▲ +1227.6% |
| 2020 | 0.61x | Rs153.46 Million | Rs250.06 Million | Rs153.10 Million | ▼ -5.3% |
| 2019 | 0.65x | Rs120.83 Million | Rs186.54 Million | Rs89.54 Million | ▼ -51.6% |
| 2018 | 1.34x | Rs395.65 Million | Rs295.91 Million | Rs257.82 Million | — |